Published in TB and Outbreaks Week, April 29th, 1996
Standard treatment regimens for drug susceptible TB, such as administration of isoniazid/rifampin/pyrazinamide for two months and then isoniazid/rifampin for four months, yield cure rates of more than 95 percent. Even when patients are resistant to isoniazid, a cure rate of more than 90 percent is achievable with the addition of ethambutol or streptomycin to the regimen. Resistance to both isoniazid and rifampin, however reduces the efficacy of treatment and is associated with failure rates of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week